Radiolabeling of tetrazines has gained increasing attention due to their important role in pretargeted imaging or therapy. The most commonly used radionuclide in PET imaging is fluorine‐ 18. For this reason, we have recently developed a method which enables the direct aromatic¹⁸F‐ fluorination of tetrazines using stannane precursors through copper‐mediated fluorinations. Herein, we further optimized this labeling procedure. 3‐(3‐fluorophenyl)‐1,2,4,5‐tetrazine was chosen for this purpose because of its high reactivity and respective limited stability during the labeling process. By optimizing parameters such as elution conditions, precursor amount, catalyst, time or temperature, the radiochemical yield (RCY) could be increased by approximately 30%. These conditions were then applied to optimize the RCY of a recently successfully developed and promising pretargeting imaging agent. This agent could be isolated in a decay corrected RCY of 14 ± 3% and Am of 201 ± 30 GBq/μmol in a synthesis time of 70 min. Consequently, the RCY increased by 27%.